Esperion Therapeutics (ESPR) Institutional Ownership $2.22 +0.01 (+0.45%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.22 +0.00 (+0.23%) As of 08/29/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Esperion Therapeutics (NASDAQ:ESPR)CurrentInstitutional OwnershipPercentage47.39%Number ofInstitutional Buyers(last 12 months)64TotalInstitutional Inflows(last 12 months)$37.78MNumber ofInstitutional Sellers(last 12 months)38TotalInstitutional Outflows(last 12 months)$101.44M Get ESPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Esperion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ESPR Institutional Buying and Selling by Quarter Esperion Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 State of Wyoming122,532$121K0.0%+36.2%0.061% 8/15/2025 Wasatch Advisors LP10,340,261$10.18M0.1%-5.4%5.217% 8/15/2025 Brevan Howard Capital Management LP78,715$77K0.0%+139.0%0.040% 8/15/2025 Bank of America Corp DE836,339$823K0.0%-45.2%0.422% 8/14/2025 The Manufacturers Life Insurance Company 72,705$72K0.0%+7.4%0.037% 8/14/2025 Qube Research & Technologies Ltd485,603$478K0.0%+238.3%0.245% 8/13/2025 Diametric Capital LP678,824$668K0.4%+57.8%0.342% 8/13/2025 Marshall Wace LLP5,312,252$5.21M0.0%+46.2%2.680% 8/13/2025 Two Seas Capital LP9,954,975$9.80M0.2%+43.6%5.023% 8/13/2025 Invesco Ltd.493,929$486K0.0%+93.3%0.249% Get the Latest News and Ratings for ESPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2025 Rhumbline Advisers275,688$271K0.0%+16.8%0.139% 8/12/2025 JPMorgan Chase & Co.561,396$553K0.0%-70.8%0.283% 8/8/2025 Intech Investment Management LLC123,040$121K0.0%+30.4%0.062% 8/8/2025 Geode Capital Management LLC4,583,988$4.51M0.0%+3.1%2.313% 8/6/2025 Summit Wealth Group LLC323,000$318K0.1%+10.2%0.163% 7/24/2025 Boomfish Wealth Group LLC45,306$45K0.0%+29.5%0.023% 7/15/2025 North Star Investment Management Corp.25,000$25K0.0%N/A0.013% 7/11/2025 UMB Bank n.a.170,000$167K0.0%N/A0.086% 7/9/2025 Sivia Capital Partners LLC25,738$25K0.0%N/A0.013% 7/8/2025 Parallel Advisors LLC127,424$125K0.0%+1,174.2%0.064% 5/19/2025 Jane Street Group LLC180,227$260K0.0%-48.3%0.091% 5/16/2025 Goldman Sachs Group Inc.1,527,286$2.20M0.0%-44.5%0.771% 5/16/2025 Jones Financial Companies Lllp192,743$278K0.0%N/A0.097% 5/16/2025 Two Seas Capital LP6,930,871$9.98M0.3%-40.0%3.498% 5/16/2025 AQR Capital Management LLC61,887$89K0.0%-68.7%0.031% 5/15/2025 Graham Capital Management L.P.487,735$702K0.0%+153.5%0.246% 5/15/2025 State of Wyoming89,936$130K0.0%+93.8%0.045% 5/14/2025 MetLife Investment Management LLC74,786$108K0.0%-36.5%0.038% 5/14/2025 CW Advisors LLC46,300$74K0.0%N/A0.023% 5/14/2025 Summit Financial LLC65,194$94K0.0%+40.1%0.033% 5/14/2025 Wellington Management Group LLP761,980$1.10M0.0%+36.0%0.385% 5/12/2025 Meridian Wealth Management LLC20,000$29K0.0%N/A0.010% 5/12/2025 Nuveen LLC3,087,700$4.45M0.0%N/A1.558% 5/12/2025 Virtu Financial LLC35,909$52K0.0%-72.8%0.018% 5/12/2025 Invesco Ltd.255,480$368K0.0%+161.1%0.129% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.822,618$1.19M0.0%-11.7%0.415% 5/9/2025 Deutsche Bank AG125,784$181K0.0%-24.3%0.063% 5/9/2025 Headlands Technologies LLC38,447$55K0.0%-84.9%0.019% 5/7/2025 SLT Holdings LLC50,000$72K0.1%+66.7%0.025% 5/7/2025 Foundations Investment Advisors LLC50,172$72K0.0%+66.3%0.025% Buffett, Gates and Bezos Dumping Stocks (Ad)The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.For the full story, click here.5/7/2025 Mackenzie Financial Corp123,115$177K0.0%-14.1%0.062% 5/5/2025 Private Advisor Group LLC40,106$58K0.0%+33.2%0.020% 5/2/2025 Victory Capital Management Inc.23,622$34K0.0%-86.4%0.012% 5/2/2025 Summit Wealth Group LLC293,000$422K0.1%+86.6%0.148% 4/29/2025 Bank of New York Mellon Corp415,141$598K0.0%-2.9%0.210% 4/22/2025 Synergy Asset Management LLC31,000$45K0.0%+3,496.3%0.016% 4/8/2025 Rhumbline Advisers236,030$340K0.0%-4.4%0.119% 3/24/2025 Wellington Management Group LLP560,276$1.23M0.0%-7.1%0.283% 2/20/2025 Mackenzie Financial Corp143,252$315K0.0%+116.1%0.073% 2/17/2025 Woodline Partners LP1,503,746$3.31M0.0%-33.0%0.763% 2/17/2025 Two Sigma Advisers LP3,616,200$7.96M0.0%+0.4%1.835% 2/17/2025 Two Sigma Investments LP3,540,361$7.79M0.0%-2.3%1.797% 2/17/2025 State of Wyoming46,410$102K0.0%-40.3%0.024% 2/17/2025 Rafferty Asset Management LLC37,056$82K0.0%N/A0.019% 2/17/2025 ProShare Advisors LLC62,549$138K0.0%+75.2%0.032% 2/17/2025Nuveen Asset Management LLC3,119,253$6.86M0.0%+48.6%1.583% 2/17/2025 Millennium Management LLC829,885$1.83M0.0%-75.6%0.421% 2/17/2025 Gotham Asset Management LLC11,977$26K0.0%-49.8%0.006% 2/17/2025 Graham Capital Management L.P.192,415$423K0.0%-19.0%0.098% 2/17/2025 Deutsche Bank AG166,220$366K0.0%-89.3%0.084% 2/17/2025 D. E. Shaw & Co. Inc.251,592$554K0.0%+152.7%0.128% 2/17/2025 Crestline Management LP28,745$63K0.0%N/A0.015% 2/17/2025 Bayesian Capital Management LP65,900$145K0.0%N/A0.033% 2/17/2025 Bank of America Corp DE1,629,980$3.59M0.0%+45.1%0.827% 2/17/2025 BNP Paribas Financial Markets153,212$337K0.0%+24.2%0.078% 2/14/2025 Northern Trust Corp1,540,084$3.39M0.0%+4.5%0.782% 2/14/2025 Indaba Capital Management L.P.3,000,000$6.60M3.2%-91.1%1.523% 2/14/2025 Susquehanna Fundamental Investments LLC65,260$144K0.0%N/A0.033% 2/14/2025 Virtus ETF Advisers LLC137,120$302K0.1%+21.2%0.070% 2/14/2025 Price T Rowe Associates Inc. MD123,896$273K0.0%+15.3%0.063% 2/14/2025 MetLife Investment Management LLC117,732$259K0.0%+65.7%0.060% 2/13/2025 Wasatch Advisors LP24,482,258$53.86M0.3%+4.9%12.425% 2/13/2025 XTX Topco Ltd24,494$54K0.0%-84.3%0.012% 2/13/2025 Barclays PLC359,235$791K0.0%+16.0%0.182% 2/13/2025 CenterBook Partners LP1,306,259$2.87M0.2%-58.0%0.663% 2/13/2025 Raymond James Financial Inc.44,658$98K0.0%N/A0.023% 2/13/2025 Renaissance Technologies LLC578,800$1.27M0.0%-36.7%0.294% 2/13/2025 Invesco Ltd.97,833$215K0.0%+15.5%0.050% 2/13/2025 Rhenman & Partners Asset Management AB1,915,000$4.21M0.4%-3.0%0.972% 2/12/2025 Rangeley Capital LLC107,000$235K0.2%N/A0.054% 2/12/2025 Geode Capital Management LLC4,339,948$9.55M0.0%+0.2%2.203% 2/12/2025 Headlands Technologies LLC255,066$561K0.1%+55.0%0.129% 2/12/2025 Diametric Capital LP354,010$779K0.5%-46.9%0.180% 2/12/2025 Summit Financial LLC46,528$102K0.0%+18.2%0.024% 2/12/2025 Alliancebernstein L.P.159,260$350K0.0%-12.5%0.081% 2/12/2025 Wellington Management Group LLP560,276$1.23M0.0%-7.1%0.284% 2/12/2025 JPMorgan Chase & Co.2,454,216$5.40M0.0%+18.6%1.246% 2/11/2025 Prudential Financial Inc.33,570$74K0.0%-32.3%0.017% 2/11/2025 Corebridge Financial Inc.93,944$207K0.0%-7.0%0.048% 2/11/2025 Vanguard Group Inc.11,715,748$25.78M0.0%-10.2%5.946% Forget Tesla — This Tiny AI Stock Is Musk’s Real Play (Ad)While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.See the full details on this “backdoor” Musk bet here2/11/2025 Virtu Financial LLC132,234$291K0.0%N/A0.067% 2/11/2025 Platinum Investment Management Ltd.840,052$1.85M0.1%-23.1%0.426% 2/11/2025 Intech Investment Management LLC81,385$179K0.0%+43.0%0.041% 2/10/2025 Cibc World Markets Corp17,683$39K0.0%N/A0.009% 2/10/2025 Corient Private Wealth LLC50,745$112K0.0%-68.2%0.026% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.932,008$2.05M0.0%+31.0%0.473% 2/7/2025 SLT Holdings LLC30,000$66K0.1%N/A0.015% 2/6/2025 Raymond James Financial Inc.44,658$98K0.0%N/A0.023% 2/6/2025 Victory Capital Management Inc.173,083$381K0.0%+602.8%0.088% 2/4/2025 Summit Wealth Group LLC157,000$345K0.1%+292.5%0.080% (Data available from 1/1/2016 forward) ESPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ESPR shares? During the previous two years, 129 institutional investors and hedge funds held shares of Esperion Therapeutics. The most heavily invested institutionals were Bellevue Group AG ($26.65M), Vanguard Group Inc. ($25.78M), Great Point Partners LLC ($12.86M), Wasatch Advisors LP ($10.18M), Two Seas Capital LP ($9.80M), Armistice Capital LLC ($9.57M), and Two Sigma Advisers LP ($7.96M).Learn more on Esperion Therapeutics' institutional investors. What percentage of Esperion Therapeutics' stock is owned by institutional investors? 47.39% of Esperion Therapeutics' stock is owned by institutional investors. Learn more on ESPR's institutional investor holdings. Which institutional investors have been buying Esperion Therapeutics' stock? Of the 100 institutional investors that purchased Esperion Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wasatch Advisors LP ($7.86M), Bellevue Group AG ($5.74M), Marshall Wace LLP ($3.77M), Vanguard Group Inc. ($3.69M), Armistice Capital LLC ($3.20M), Nuveen LLC ($3.09M), and Two Seas Capital LP ($3.02M). How much institutional buying is happening at Esperion Therapeutics? Institutional investors have bought a total of 24,234,992 shares in the last 24 months. This purchase volume represents approximately $37.78M in transactions. Which of Esperion Therapeutics' major shareholders have been selling company stock? Of the 38 institutional investors that sold Esperion Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Indaba Capital Management L.P. ($30.75M), Two Seas Capital LP ($4.62M), Millennium Management LLC ($2.57M), CenterBook Partners LP ($1.81M), Deutsche Bank AG ($1.43M), JPMorgan Chase & Co. ($1.36M), and Vanguard Group Inc. ($1.33M). How much institutional selling is happening at Esperion Therapeutics? Institutional investors have sold a total of 50,049,462 shares in the last 24 months. This volume of shares sold represents approximately $101.44M in transactions. Related Companies Apogee Therapeutics Institutional Ownership Beam Therapeutics Institutional Ownership Twist Bioscience Institutional Ownership Immunocore Institutional Ownership Cidara Therapeutics Institutional Ownership Aurinia Pharmaceuticals Institutional Ownership Biohaven Institutional Ownership WAVE Life Sciences Institutional Ownership Travere Therapeutics Institutional Ownership Tilray Brands Institutional Ownership This page (NASDAQ:ESPR) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Esperion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Esperion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ESPR Stock Alerts